Founded 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California.
Piper Jaffray (NYSE: PJC) is a leading investment bank focused on mergers and acquisitions, public offerings, public finance, institutional brokerage, investment management and research. Founded in 1895, the firm is headquartered in Minneapolis with offices across the U.S. and in London, Aberdeen, Zurich and Hong Kong.
Pliant Therapeutics is a clinical stage biotechnology company unraveling and targeting the key biological pathways driving fibrosis. By leveraging our powerful product discovery engine, Pliant is developing novel therapeutics that seek to halt progression of fibrotic diseases — ultimately, preserving organ function.
We are combining world-class expertise in TGF-β1 signaling and integrin biology, medicinal chemistry, translational screening technologies, and clinical insights to create best-in-class, tissue-specific inhibitors of fibrotic diseases. Our product engine has the potential to benefit numerous patient populations, as we are targeting fibrosis in a variety of organs and conditions including lung (IPF), liver (primary sclerosing cholangitis, NASH and cirrhosis), kidney (renal fibrosis), skin (scleroderma) and the gastrointestinal tract (stricturing Crohn’s disease).
Pliant’s co-founders include world-renowned researchers from the University of California, San Francisco, who bring broad experience in fibrosis biology and small-molecule chemistry. Together, the Pliant team is dedicated to translating scientific advances in fibrosis biology into novel therapies for patients in need.
Veran Medical Technologies
Veran is a privately held medical device company headquartered in St. Louis, MO. The company’s main focus is assisting physicians in the early diagnosis and treatment of lung cancer. In the United States, lung cancer kills more people each year than breast, prostate, pancreatic and colon cancers combined. Veran has developed and commercialized an FDA cleared, next generation electromagnetic thoracic navigation platform called the SPiN Thoracic Navigation System™ which features SPiN Perc™—a proprietary technology that allows physicians to seamlessly transition from navigated bronchoscopy to navigated TTNA in a single procedure. Veran’s breakthrough technology has been adopted by leading cancer centers throughout the United States.
American Thoracic Society
Founded in 1905, the American Thoracic Society is the world's leading medical association dedicated to advancing pulmonary, critical care and sleep medicine. The Society’s more than 16,000 members prevent and fight respiratory disease around the globe through research, education, patient care and advocacy. The ATS publishes three journals, the American Journal of Respiratory and Critical Care Medicine, the American Journal of Respiratory Cell and Molecular Biology and the Annals of the American Thoracic Society.
touchRESPIRATORY.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
US Respiratory & Pulmonary Diseases is a peer-reviewed, free-to-access, annual journal specializing in the publication of balanced and comprehensive review articles written by leading authorities to address the most important and salient developments in the respiratory care and pulmonary disease fields. The aim of these reviews is to break down the high science from 'data-rich' primary papers and provide practical advice and opinion on how this information can help physicians in the day to day clinical setting. Editorials, special reports, case reports, and original research articles are also featured to promote discussion and learning amongst physicians, clinicians, researchers and related healthcare professionals.
The journals are lead by expert Editorial Boards from a variety of respiratory and pulmonary disciplines, who assist in the commissioning of independent review articles and provide expert editorial advice on the most salient topics within the fields.